Fulcrum Therapeutics (FULC) Shares Issued (2019 - 2025)
Historic Shares Issued for Fulcrum Therapeutics (FULC) over the last 7 years, with Q3 2025 value amounting to $64000.0.
- Fulcrum Therapeutics' Shares Issued fell 8992.13% to $64000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $448000.0, marking a year-over-year decrease of 8481.36%. This contributed to the annual value of $2.7 million for FY2024, which is 25341.06% up from last year.
- Latest data reveals that Fulcrum Therapeutics reported Shares Issued of $64000.0 as of Q3 2025, which was down 8992.13% from $301000.0 recorded in Q2 2025.
- Fulcrum Therapeutics' 5-year Shares Issued high stood at $2.8 million for Q2 2022, and its period low was $64000.0 during Q3 2025.
- In the last 5 years, Fulcrum Therapeutics' Shares Issued had a median value of $301000.0 in 2025 and averaged $651470.6.
- The largest annual percentage gain for Fulcrum Therapeutics' Shares Issued in the last 5 years was 160316.46% (2021), contrasted with its biggest fall of 9963.95% (2021).
- Over the past 5 years, Fulcrum Therapeutics' Shares Issued (Quarter) stood at $969000.0 in 2021, then plummeted by 72.45% to $267000.0 in 2022, then grew by 7.49% to $287000.0 in 2023, then crashed by 71.08% to $83000.0 in 2024, then decreased by 22.89% to $64000.0 in 2025.
- Its Shares Issued was $64000.0 in Q3 2025, compared to $301000.0 in Q2 2025 and $83000.0 in Q4 2024.